Pharmaceutical Business Review
Return to: PBR Home | Companies

Helix BioPharma Corp

Helix BioPharma Corp
Suite 205
9120 Leslie Street
Canada
Phone: 1 905 8412300
Fax: 19-05-8412244
www.helixbiopharma.com

No. employees: 10
Turnover: 00.00 (US$m)
Financial year end: July

Company Overview

Top Competitors


Key Employees

Sven Rohmann, Ph.D., M.D.

Chairman, Executive Board

Marek Orlowski, M.D.

Director, Non Executive Board

Slawomir Majewski

Director, Non Executive Board

Sylwester Cacek

Director, Non Executive Board

George J. Anders, Ph.D.

Director, Non Executive Board

Theodore J. Witek, Ph.D.

Director, Non Executive Board

Heman Chao, Ph.D.

Chief Scientific Officer, Chief Executive Officer, Senior Management

Frank Michalargias

Chief Financial Officer, Senior Management

Steve Demas

Chief Operating Officer, Senior Management

Pawel Wisniewski

Chief Executive Officer Poland Operations, Senior Management

Locations/Subsidiaries


Suite 205,
9120 Leslie Street,
Ontario,
Canada
Phone: 1 905 8412300
Fax: 1 905 8412244

Helix Product Development (Ireland) Ltd

Commercial Physical Research, Nsk,
66 Lower Leeson Street,
Ireland

Helix Polska

Poland

Helix Polska Sp Zoo

Poland

Products/Services


Products:

  • Product Pipeline:
  • L-DOS47 monotherapy NSCLC
  • L-DOS47 combination NSCLC
  • L-DOS47 Combo Other Indications
  • L-DOS47 Combo Immune Checkpoints
  • V-DOS47
  • CAR-T Solid Tumors (CEACAM6)
  • CAR-T Hematologic Tumors (Bispecific)